ReviewFrontiers in plant science2026
Beyond GMOs: transgene-free gene-edited crops for global food security.
Review in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transgene-free gene-editing has transformed the genomic landscape of crops by enabling targeted, precise, and predictable genetic outcomes without integrating any foreign DNA into the host genome. It has significantly reduced production time and costs, and the regulatory burden for transgene-free gene-edited crops, while improving social acceptance compared with classical transgenic crops. This review compares the transgene-free gene-edited, transgenic, and cisgenic crops. We also focus on core methods for developing transgene-free gene-edited crops, particularly ribonucleoprotein (RNP), transient expression, the transgene killer method, and HI-edit technology. We highlight the practical examples summarizing CRISPR applications for transgene-free gene-edited crops, including cereals, legumes, and oilseeds, and horticultural crops. We also analyze the rapidly evolving global regulatory landscape of transgene-free gene-edited crops, including the recent European Union movement towards differentiated oversight for certain "new genomic techniques (NGTs)" that do not introduce foreign DNA, while maintaining the strict risk assessment for complex modifications. We also summarize the social, ethical, and public perception aspects of transgene-free gene-edited crops compared with traditional GMOs. Finally, we highlight the emerging role of AI in developing precise transgene-free gene-edited crops and the contributions these crops make to global food security. Collectively, this evidence supports the growing role of transgene-free gene-edited crops in scientific developments and real-world agricultural deployment, with remaining bottlenecks in delivery for recalcitrant crops, scalable and universal regulation, detection and traceability of the Cas footprints, and equitable access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.